Related Experiment Videos

Streptomycin perfusion of the labyrinth

J J Shea1, C H Norris

  • 1Shea Clinic, Shea Clinic Foundation, Memphis, Tennessee.

Insights

Meniere's disease may involve an immune cause beyond endolymphatic hydrops. Streptomycin offers a direct treatment for dizzy spells by destroying vestibular receptors without harming hearing.

Area of Science:

  • Otolaryngology
  • Neurology
  • Immunology

Background:

  • Meniere's disease is characterized by hearing loss, tinnitus, and vertigo.
  • Endolymphatic hydrops is the presumed cause, but not all cases align.
  • An unknown immune-mediated factor may contribute to Meniere's disease.

Purpose of the Study:

  • To explore potential causes of Meniere's disease beyond endolymphatic hydrops.
  • To evaluate the efficacy of current treatments for Meniere's disease.
  • To investigate streptomycin as a direct treatment for Meniere's disease symptoms.

Main Methods:

  • Review of clinical presentations and pathological findings in Meniere's disease.
  • Analysis of the effectiveness of medical (diet, diuretics, steroids) and surgical treatments.
  • Examination of streptomycin's effect on vestibular receptors, referencing animal studies.

Main Results:

  • Endolymphatic hydrops is present in most, but not all, Meniere's disease patients.
  • Conventional treatments offer limited long-term benefit for vertigo and hearing loss.
  • Streptomycin effectively relieves dizzy attacks by selectively destroying vestibular receptors.

Conclusions:

  • Meniere's disease likely has an immune-mediated component exacerbating endolymphatic hydrops.
  • Surgical interventions like vestibular neurectomy are risky and do not improve hearing.
  • Streptomycin presents a direct, effective method for controlling vertigo in Meniere's disease.

Related Concept Videos